All articles tagged with #dr congo
DR Congo and Rwanda-backed M23 rebels agreed a roadmap to resume peace talks and establish a ceasefire monitoring mechanism under the US-brokered Doha Framework signed in 2025, with a first verification mission planned in Minembwe; however, disputes linger over sanctions, detainees, and the pace of political reforms.
DR Congo will test the Ervebo Ebola vaccine against the Bundibugyo strain in a clinical trial as the outbreak expands rapidly, with about 2,500 deaths reported. The WHO says infections are growing exponentially across the north and east. The plan allocates 20,000 doses for the trial and 50,000 for frontline health workers, in a bid to broaden protection beyond the Zaïre strain; the response is complicated by conflict, misdiagnosis early on, burial practices, and new movement restrictions imposed by the M23 rebel group to limit spread.
DR Congo will receive 70,000 Ervebo Ebola vaccine doses from a global stockpile, including 20,000 for a late-stage trial on the Bundibugyo virus; Ervebo is not yet proven against Bundibugyo, while 50,000 doses will go to frontline health workers, funded by Gavi. The outbreak has killed about 2,476 people out of 5,208 confirmed cases, prompting intensified UN/WHO-led response and vaccination efforts.
An Ebola outbreak in eastern DR Congo, driven by the Bundibugyo variant, has infected over 5,100 people and killed about 2,420, making it the deadliest, fastest‑moving outbreak in the country’s history. The WHO says the situation is far from under control, with many deaths occurring in communities and transmission spanning six provinces. Response efforts—surveillance, treatment capacity, and experimental vaccines—are being scaled up, but funding shortfalls and delayed detection hinder containment. Uganda’s previous Bundibugyo experience offers some lessons, but the cross-border risk remains high for neighboring countries.
The World Health Organization has declared the Democratic Republic of the Congo Ebola outbreak a global health emergency as infections surpassed 5,000 and deaths exceeded 2,300, warning the epidemic is far from under control amid conflict, misinformation and the absence of an approved vaccine or treatment for the Bundibugyo strain. Officials say the response must identify and break every transmission chain, scale up community engagement, and repurpose transport networks (including motorbike riders) for surveillance, even as experimental vaccines advance.
DR Congo's Ebola outbreak has become the deadliest in the country's history, with 2,325 deaths and 4,945 cases; the Bundibugyo strain has no approved vaccines or treatments, and weak health infrastructure and ongoing conflict have hindered response, as UN and WHO urge speed, scale, and solidarity to prevent further spread and the case fatality rate rises toward 46%.
A Bundibugyo-strain Ebola outbreak in DR Congo has spread to Bas-Uele, bringing the number of affected provinces to six; the death toll is about 2,128 from 4,566 infections. WHO warns the spread is faster than previous outbreaks and could become the deadliest on record, while two vaccines and other treatments are in trials as health officials push containment efforts.
The 2026 Bundibugyo Ebola outbreak in the Democratic Republic of Congo is on track to become the deadliest, with about 4,300 cases and 2,000 deaths since May; the virus is ahead of response efforts, only around 30% of cases are reached due to instability, and there is no approved vaccine or therapy for this strain, though Oxford-based vaccine trials and antiviral studies are progressing.
The Ebola outbreak in the Democratic Republic of Congo began at least three months before its May 15 declaration and is now outpacing authorities. With more than 1,900 deaths, it ranks as the second-worst outbreak, concentrated in the insecure eastern region where health workers reach only about 30% of cases, and there are no approved vaccines or therapies. Early misdiagnosis as malaria or typhoid helped delay detection as the virus spread.
Frontline health workers in Bunia, DR Congo, say they have not received government wages while fighting what the WHO calls the largest Ebola outbreak in the country, threatening strikes or withdrawals as MSF notes timely pay is crucial; the outbreak, fueled by conflict and mistrust, has strained facilities and raised the risk that unpaid wages could undermine efforts to contain the virus.
DR Congo is facing its largest Ebola outbreak on record, caused by the Bundibugyo strain, with 3,605 confirmed cases and 1,587 deaths (about 44% fatal) as of July 30, 2026, surpassing the 2018–2020 outbreak. No approved vaccine or treatment exists yet, though vaccines are in development in the UK and Singapore. The outbreak is intensifying, with the highest weekly totals (567 cases, 296 deaths) and is hampered by insecurity, displacement, and cross-border movement. The epicenter is Ituri Province, with spread to North and South Kivu and cases in Uganda; a few cases have been treated in Europe. WHO notes ongoing transmission and progress on vaccine development as trials proceed."
DRC’s Ebola outbreak has 3,442 cases and 1,521 deaths (up about 50% in a week), with no vaccine for the Bundibugyo strain and containment hampered by ongoing conflict, limited access, reporting backlogs, and community mistrust; Ituri province accounts for about 90% of cases, while unsafe handling of bodies and attacks on health facilities fuel spread, though WHO says global risk remains low.
An experimental vaccine targeting the Bundibugro strain of Ebola has entered its first-in-human phase to evaluate safety and immune response. It is one of four Bundibugro vaccines in development; existing Zaire-targeted vaccines do not work against Bundibugro. Oxford-led trials will be followed by a second small Uganda study and a larger efficacy trial in DR Congo. The Serum Institute has produced 600,000 doses if trials succeed. The DR Congo outbreak has over 2,500 confirmed cases and about 1,000 deaths.
More than 1,000 people have died and about 2,473 cases have been recorded in DR Congo’s Bundibugyo Ebola outbreak—the fastest on record—driven by a lack of vaccines or treatments for this strain, ongoing conflict, and community resistance that fuels undetected transmission and poses safety risks to health workers.
DR Congo’s Bundibugyo Ebola outbreak has killed 999 people in the DRC and 2 in Uganda, with 2,473 cases and 737 patients in isolation; declared in May in Ituri, the outbreak is spreading faster than any prior Ebola event, and there is no approved vaccine or treatment for this strain, prompting urgent calls for a stepped-up global response from WHO and Africa CDC.